Company Filing History:
Years Active: 2013-2017
Title: Emmanuelle Godefroy: Innovator in Immunology and Cancer Research
Introduction
Emmanuelle Godefroy is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of immunology, particularly in the development of methods and agents for targeting matrix metalloproteinase-2 (MMP-2) in cancer therapies. With a total of 3 patents, her work is paving the way for innovative treatments for tumors expressing MMP-2, such as melanoma.
Latest Patents
Godefroy's latest patents focus on methods, agents, and peptides for inhibiting MMP-2 signaling. One of her notable inventions describes screening assays and methods for identifying modulator agents or compounds that affect MMP-2 mediated activation of toll-like receptor-2 (TLR-2). This invention encompasses pharmaceutical and immunogenic compositions that include agents or compounds capable of modulating MMP-2 mediated activation of TLR-2. Additionally, her work envisions methods for using MMP-2 peptides in pharmaceutical compositions and vaccines to enhance T cell responses to MMP-2 expressing tumors.
Another significant patent relates to inducing an immune response to MMP-2 expressing tumors. This invention aims to enhance, modulate, or stimulate the immune response to tumors like melanoma. Godefroy's methods provide means to activate effective responses to MMP-2 expressing tumors and modulate the immune system's response, particularly focusing on CD4+ T cell responses.
Career Highlights
Emmanuelle Godefroy is affiliated with New York University, where she continues her research and innovation in the field of cancer immunotherapy. Her work has garnered attention for its potential to improve treatment outcomes for patients with MMP-2 expressing tumors.
Collaborations
Godefroy collaborates with notable colleagues, including Nina Bhardwaj and Francine Jotereau, who contribute to her research efforts in immunology and cancer treatment.
Conclusion
Emmanuelle Godefroy's innovative work in the field of immunology and cancer research is making significant strides in developing effective therapies for MMP-2 expressing tumors. Her contributions are vital in the ongoing fight against cancer, and her patents reflect her commitment to advancing medical science.